FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
Promacta receives FDA Priority Review for first-line treatment of SAA based on data showing 52% complete response rate and 85% overall response rate when added to standard immunosuppressive therapy (IST)
Regulatory action underscores the treatment poten... Biopharmaceuticals, FDA Novartis, Promacta, eltrombopag, aplastic anemia, TPO receptor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news
Strangers Become Heroes Everyday: How Your Platelet Donations Can Help Save Lives
When some people hear “blood donation” they feel queasy or uncomfortable but for patients who need blood transfusions, they feel grateful. Liviya Anderson was diagnosed with aplastic anemia when she...
{This is a content summary only. Click the blog post title to continue reading this post, share your comments, browse the blog and more!} (Source: Red Cross Chat)
Source: Red Cross Chat - May 14, 2018 Category: International Medicine & Public Health Authors: American Red Cross Tags: Blood aplastic anemia blood donation Liviya Platelet Donation platelets Source Type: news
Celiac Disease Associated With Aplastic Anemia in a 6-Year-Old Celiac Disease Associated With Aplastic Anemia in a 6-Year-Old
Many hematological disorders have been associated with celiac disease. This case represents the fourth associated with aplastic anemia in children--might it be more common than thought?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 20, 2018 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news
Two year old boy needs life-saving donors after rare blood disorder diagnosis
CANCER symptoms affects almost 360,000 new people in the UK every year. This International Childhood Cancer Day, blood cancer charity Anthony Nolan are raising awareness of rare disorders, as two-year old Jacob needs a stem cell donor for his aplastic anaemia condition. (Source: Daily Express - Health)
Source: Daily Express - Health - February 15, 2018 Category: Consumer Health News Source Type: news
Novartis drug Promacta(R) receives FDA Breakthrough Therapy designation for first-line use in severe aplastic anemia (SAA)
Data supporting designation showed over half of treatment-naïve SAA patients achieved complete response with Promacta when given with standard immunosuppressive therapy, with overall response rate of 85%[1]
Promacta is the only TPO receptor agonist... Biopharmaceuticals, FDA Novartis, Promacta, eltrombopag, aplastic anemia, TPO receptor agonist (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2018 Category: Pharmaceuticals Source Type: news
Novartis' Promacta receives FDA breakthrough designation for new indication
ZURICH (Reuters) - Novartis drug Promacta has received breakthrough therapy designation from the U.S. Food and Drug Administration for first-line treatment of severe aplastic anemia (SAA). (Source: Reuters: Health)
Source: Reuters: Health - January 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Can Gout Cause Aplastic Anemia?
Title: Can Gout Cause Aplastic Anemia?Category: Doctor's& Expert's views on SymptomsCreated: 10/24/2017 12:00:00 AMLast Editorial Review: 10/24/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - October 24, 2017 Category: Rheumatology Source Type: news
Immunosuppressant Response Predicts Aplastic Anemia Survival
Overall survival superior in therapy responders; shorter relapse - free survival with partial response (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 7, 2017 Category: Cancer & Oncology Tags: Oncology, Journal, Source Type: news
Gamida Cell launches severe aplastic anemia trial
Gamida Cell said today that the first patient has been transplanted in a study of its CordIn product for patients with severe aplastic anemia or hypoplastic myelodysplastic syndrome.
The product is designed for patients with rare genetic diseases who have no fully-matched donors for a bone marrow transplantation. Gamida Cell said it is also evaluating its CordIn therapy for patients with sickle cell disease.
Get the full story at our sister site, Drug Delivery Business News.
The post Gamida Cell launches severe aplastic anemia trial appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 21, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Research & Development Stem Cells Gamida Cell Source Type: news
Gamida Cell Announces First Patient Transplanted in Phase 1/2 Study of CordIn for Severe Aplastic Anemia and Hypoplastic MDS
This investigator initiated study is being conducted in collaboration with the U.S. National Heart, Lung and Blood Institute (NHLBI)
JERUSALEM, Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) -- The first subject has been transplanted in an in... Biopharmaceuticals Gamida Cell, Cordin, aplastic anemia, myelodysplastic syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 21, 2017 Category: Pharmaceuticals Source Type: news
What Causes Anemia?
Discussion
One of the most common problems in pediatrics is anemia. It is defined as “a lower than normal value for the related measurements of hemoglobin, hematocrit, and number of red blood cells”, usually 2 standard deviations below the normal for age. Normal hematological values change with age. For a discussion of which values are used click here.
The most common type of anemia in childhood is iron deficiency which is commonly caused by inadequate stores (e.g. premature infant), inadequate intake (e.g. poor nutrition) or blood loss (e.g. menses). Anemia screening is recommended at age 9-12 months, and for...
Source: PediatricEducation.org - May 15, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Snapchat's Marie Curie Filter Includes Makeup And People Aren't Happy
Snapchat unveiled a few new photo filters for International Women’s Day on Wednesday, and one of them is ... a problem.
To celebrate the day, the app rolled out filters honoring famous women: Frida Kahlo, Rosa Parks, and Marie Curie. The intention to be inclusive is there and appreciated. But there’s an issue with the Marie Curie filter ― she’s inexplicably got a smoky eye and fake eyelashes.
Shoutout to @Snapchat for adding eyelashes to the Marie Curie filter. Forgot that's what she was famous for. #InternationalWomensDay pic.twitter.com/4gN2QjzR5B— Katy St Clair (@Selfies_AndCat...
Source: Science - The Huffington Post - March 8, 2017 Category: Science Source Type: news
Parents make tough decision to save sick son by having a 'saviour sibling'
Mohamad Al Sabbagh has severe idiopathic aplastic anemia. Hoping to save his life with the right match for a stem cell transplant, his parents are considering having a baby and implanting the infant's stem cells into their son. (Source: CBC | Health)
Source: CBC | Health - March 8, 2017 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news
Sixteen aplastic anemia patients free of disease after bone marrow transplant and chemo
Physicians report they have successfully treated 16 patients with a rare and lethal form of bone marrow failure called severe aplastic anemia using partially matched bone marrow transplants followed by two high doses of a common chemotherapy drug. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 7, 2017 Category: Science Source Type: news
16 aplastic anemia patients free of disease after bone marrow transplant and chemo
(Johns Hopkins Medicine) Physicians at the Johns Hopkins Kimmel Cancer Center report they have successfully treated 16 patients with a rare and lethal form of bone marrow failure called severe aplastic anemia using partially matched bone marrow transplants followed by two high doses of a common chemotherapy drug. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 7, 2017 Category: Cancer & Oncology Source Type: news
